Showing results (161-170 of 1,337) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|April 21, 2020
Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate modelsCynthia Lester McCully, Louis T Rodgers, Rafael Cruz, et al.
Neuro-Oncology Advances|September 22, 2025
Is tumor shape associated with molecular diagnosis, extent of resection, or postoperative focal deficits in diffuse low-grade gliomas?Claes Johnstad, Ingerid Reinertsen, Alba Corell, et al.
Neuro-Oncology Advances|September 22, 2025
Guiding principles for adult CNS tumor treatment programsVincent Rock, Manmeet S Ahluwalia, Matt Anthony, et al.
Neuro-Oncology Advances|September 29, 2025
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic reviewPhilipp Lohmann, Laura Schäfer, Sandra Krause, et al.
Neuro-Oncology Advances|September 22, 2025
Profiling the immune tumor microenvironment of pediatric brain tumors with cavitron ultrasonic surgical aspirator (CUSA)-derived tissue fragmentsJoyce I Meesters-Ensing, Mariëtte E G Kranendonk, Raoull Hoogendijk, et al.
Neuro-Oncology Advances|August 13, 2025
Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trialNicholas F Brown, Catherine McBain, Lucy Brazil, et al.
Neuro-Oncology Advances|August 1, 2025
Prediction of early distant brain failure after stereotactic radiotherapy for brain metastasesMoncef Morjani, Brieg Dissaux, Olivier Pradier, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Neuro-Oncology Advances|July 28, 2025
Current understanding of the role of DNA methylation in pituitary neuroendocrine tumorsRacheal Peterson, David J Cote, Gabriel Zada
Neuro-Oncology Advances|August 11, 2021
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune responseMarco Pizzocri, Francesca Re, Elisabetta Stanzani, et al.
Pageof 134